Torigen Pharmaceuticals is a pioneering company based in Farmington, CT, that is revolutionizing the treatment of diseases of chronic inflammation in pets. With a focus on targeting the disease itself rather than just the symptoms, Torigen offers innovative immunotherapy platforms, including a cancer vaccine, that stimulate the immune system to specifically target cancer cells in individual patients.
By presenting a wide range of tumor-associated antigens to the immune system, Torigen's Autologous Prescription Product holds exciting potential for pets with cancer, increasing the likelihood of a successful immune response. With a commitment to advancing veterinary medicine, Torigen is changing the way cancer is treated in both human and veterinary medicine.
Generated from the website